The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 04 August, 2020, 11:33 PM IST | E-Paper
Search
+

    Prabha Raghavan

    Articles by the author

    Budget 2019: Government increases allocation for Ayushman Bharat to Rs 6,400 croreGovernment may revise compensation formula for 'faulty' Johnson & Johnson hip implant patientsSingapore court dismisses Singh brothers' appeal against Daiichi Sankyo's arbitration awardNo restrictions on online sales of medicines for now: Madras HC
    Madras High Court reserves order on lifting e-pharmacies banDelhi High Court seeks government reply on unsafe drugs ban pleaGenerico raises $3m in Series A fundingWith hyper-competitive workplaces, should mental illness be treated like any other ailment?
    Delhi High Court quashes ban on sale of Oxytocin by private drug makersSC stalls IHH's acquisition of Fortis HealthcareRestrictive Delhi HC order pushes India's online pharmacies on the backfootDelhi High Court denies interim relief to Johnson & Johnson in compensation case
    Johnson & Johnson moves Delhi High Court against government orders to compensate faulty hip implant patientsPatients unhappy with proposed compensation formula for faulty Johnson & Johnson hip implantsFaulty medical devices: Patients can seek compensationPatients with faulty Johnson & Johnson hip implants to be compensated up to Rs 1.23 crore
    Government plans database of drugs to prevent use of similar brand namesGujarat tops in implementing Ayushman BharatIHH to review Fortis funding requirements, says CEO Tan See LengDelhi HC bars realty company linked to Fortis promoters from selling assets
    IHH picks up 31% stake in Fortis, appoints four board membersIHH CEO Tan See Leng to join Fortis boardFortis Healthcare CEO Bhavdeep Singh quitsDelhi High Court to hear Daiichi's case to block Fortis deal on November 15
    Singh brothers & Daiichi case: High Court orders debtors not to sell assetsDelhi High Court orders seven companies owing Singh brothers money not to part with propertiesDaiichi alleges fraudulent siphoning of over Rs 2,000 crore by Singh brothersSebi directs Singh brothers, 8 other entities to repay over Rs 403 crore to Fortis Healthcare
    Faulty hip implants: Johnson & Johnson victims rue government panel's role in compensationDrug makers may have to pay 5 times more for pharma importsShivinder Singh offers to pay own share of Daiichi Sankyo's Rs 3,500-cr awardSupreme Court seeks Centre's response on faulty hip implants by Johnson & Johnson
    What the Doctor orders: Ground report on Ayushman Bharat from Uttar Pradesh and BiharAt Patna Medical College, two Ayushman signages lost in the confusionPM Modi invokes Ambedkar, Deendayal at Ayushman launchCentre begins Ayushman Bharat outreach
    CCI probe finds unfair practices by three drug companiesJohnson & Johnson has to pay patients cleared by government panel: Health ministry officialSC exempts Saridon, Piriton Expectorant from government's ban listA Johnson & Johnson helpline that really doesn’t help people seeking compensation
    Govt seeks help from IT biggies to make Ayushman insurance scheme fraud freeGovernment prohibits 328 fixed dose combinationsAyushman Bharat: Some states cite polls to delay health mission rolloutHealth ministry to ban 328 combination medicines over safety concerns
    Johnson & Johnson case: Parliament panel members lash out at CDSCOSupreme Court prescribes pain relief for 15 banned combination drugsMalvinder, Godhwani colluded to divert Rs 1,223 crore from Religare and FortisJ&J to work with govt to provide "further" compensation to ASR hip implant patients
    NCLT tells Malvinder, Shivinder Singh to maintain status quo in holding companyCompensate those affected by faulty hip implants: Centre to Johnson & JohnsonDelhi High Court orders release of Rs 9 crore to Daiichi as first payment in Rs 3,500-crore arbitration awardJ&J hip implants: Govt sets up new panel to decide final compensation for patients
    New committee to decide final compensation for patients with J&J's controversial hip implantsJ&J’s subsidiary hip replacement row: A detailed timeline of events that hit this global giantIndia's oxytocin ban delayed by a month as Delhi HC hears cases against itGovt asks districts to weed out names that should not be in list of Ayushman Bharat beneficiaries
    Maharashtra FDA ex-chief accuses DCGI of delaying action against J&JIndia's health ministry still 'deliberating' on findings on J&J's faulty hip implants, says JP NaddaJ&J may have to compensate for faulty hip implantsHealth ministry sends medicines to Kerala to deal with aftermath of floods
    Ayushman Bharat scheme launch on sept 25Can Indu Bhushan deliver PM Modi’s promise of healthcare?Shareholders vote to pass Fortis-IHH dealDelhi High Court says Malvinder, Shivinder Singh cannot operate bank accounts
    Health ministry likely to ban over 300 combo drugsVote in favour of Fortis-IHH deal, says proxy advisory firmGovernment hospitals may be told to buy ‘auto-disable’ syringesDelhi HC directs Malvinder and Shivinder to appear at proceedings in Daiichi's case
    Common Service Centers to help in implementation of Ayushman BharatBengal in talks with Bajaj Allianz for ‘Ayushman Bharat’Working group may vet plan to check fake drugsPanel recommends ban on 343 fixed dose combination medicines
    AstraZeneca sues DRL on patent
    AstraZeneca sues DRL on patent
    24 Jul 2018 10:57 PM IST
    Health Ministry may await DISHA from BN Srikrishna reportWest Bengal to launch Ayushman Bharat under joint bannerDaiichi Sankyo moves Delhi HC to block Fortis-IHH deal
    Government to hand-deliver 11 crore Ayushman CardsHDFC ltd takes Malvinder and Shivinder Singh's holding company to NCLT over duesReligare Finvest claims Rs 1,900 crore from 19 firms ‘known to’ Malvinder and Shivinder SinghAadhaar must for Ayushman Bharat; apply for UID by March 2019: Government
    Fortis board to decide on IHH, Manipal-TPG bids this week
    The Economic Times